Get the full picture with
Molecular-level
Insights
CEoT Lunch Symposium
Sponsored by Natera
Saturday, Feb. 27
1:30 – 2:45pm (EST)
Theater 2
Molecular-level Insights in Kidney Transplant Care: Prospera Deep Dive
Personalized care with Prospera
Suphamai Bunnapradist, MD, MS
Transplant Nephrologist and Professor of Medicine, University of California Los Angeles (UCLA)
Longitudinal monitoring of anti-rejection therapy with independent assessment using Prospera and background cfDNA
Prince Mohan, MD
Medical Director, Kidney Transplant Program, Geisinger Health System
This session explores the new applications of cell-free and genomic DNA in renal transplant care management, including new data on over 1,300+ patients and in anti-rejection therapy surveillance . Transplant physicians will share their experiences incorporating Prospera into their routine care protocols.
Objectives:
- Hear how your transplant colleagues are incorporating Prospera into their routine care protocols
- Preview early data on the use of donor-derived cell-free DNA in over 1,300+ kidney recipients
- Learn why background cfDNA impacts your protocol for assessing immunosuppression therapy
This is not an official function of the CEoT Meeting and is not endorsed by AST.